Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Surgisil, LLP
WARNING LETTER
•Surgisil, LLP•September 25, 2018

Surgisil, LLP – FDA Warning Letter, Sep 25, 2018

Record Details

On April 15, 2019, the FDA issued a Warning Letter to Surgisil, LLP, following an inspection from September 20-25, 2018, at their Plano, TX facility. The inspection revealed that Surgisil's Perma Facial Implant is adulterated under section 501(f)(1)(B) of the Federal Food, Drug, and Cosmetic Act because the firm lacks an approved premarket approval (PMA) or investigational device exemption (IDE) for its current marketing.

While the Perma Facial Implant has 510(k) clearance (K071823) for use in the nose, chin, and cheeks, the FDA found that Surgisil is marketing the device for lip augmentation. This constitutes a major change in intended use, as evidenced by instructional videos and training materials specifically detailing lip implantation. The FDA highlighted anatomical differences in the lips (vascularity, high mobility, lack of bone support) that increase risks like migration, protrusion, extrusion, infection, and chronic pain when the device is used for lip augmentation.

Additionally, the FDA cited misleading promotional materials on Surgisil's website (www.surgisil.com/us/), which falsely state the Perma Facial Implant is "FDA approved," when it was only found substantially equivalent. The firm was also found to be marketing the unapproved PermaLip Implant, as indicated by its promotion on the "

Company
Surgisil, LLP
Inspection date
September 25, 2018
Product type
Devices
Office
Office of Medical Device and Radiological Health Operations
Person
  • Shari J. Shambaugh (Program Division Director)
View Company Profile

ID · 1e65c1b9-cdbd-46db-ac94-78a75a78e4cf

Violation Codes7
21 U.S.C. 321(h)21 U.S.C. 351(f)(1)(B)21 U.S.C. 360e(a)21 U.S.C. 360j(g)21 CFR 878.350021 CFR 807.9721 U.S.C. 360c(i)(1)(A)

Full citation text and observation details available on the Dashboard.

Other documents for Surgisil, LLP
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Surgisil, LLP
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.